Close Menu

At Science Progress, Scripps' Jeanne Loring explores the possibility that American researchers will soon be outsourcing their sequencing projects to China. China's sequencing capability is growing rapidly, she writes, pointing out that BGI has ordered 128 Illumina sequencers, bringing the total number of sequencers there to 157 — nearly double what the Broad Institute has. Instrument and reagent costs are only part of the price of sequencing, Loring says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.